The 6 months longitudinal profiles of specific antibodies (anti‐Spike IgG, anti‐Spike IgA, anti‐NCP IgM) and their neutralizing capacity in non‐vaccinated subjects with prior infection (I) versus vaccinated only (V) and vaccinated with prior infection (I + V) participants are presented in Figure 2. This evidence concerns the gene CD79A and infection.